This EASL Studio episode will explore state-of-the-art practices in diagnosing steatotic liver disease and stratifying patients effectively for targeted treatment in 2025. Focusing on integrating cardiometabolic risk profiling and dynamic alcohol consumption assessment, the discussion will discuss contemporary methods, frequency, and practical implementation in clinical settings to enhance precision medicine approaches.
Faculty: Aleksander Krag (Moderator), Meena Bansal (Faculty), Mattias Ekstedt (Faculty), Arun Sanyal (Faculty)